Start-up Alimera Sciences receives funding for ophthalmic products

Series A financing worth $26.75 million will be used by Alimera Sciences Inc. for acquisition and continued development of the company's ophthalmic pharmaceutical pipeline, along with commercialization of the company's over-the-counter ophthalmic products.